Paris, France et Camberley, Royaume-Uni – 3 février 2020 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), un spécialiste international du diagnostic clinique, publie aujourd’hui le bilan mensuel du nombre d’actions échangées...
Paris, France and Camberley, UK – 3 February 2020 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares...
Paris, France and Camberley, UK – 31 January 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that its molecular diagnostics division, Primerdesign, has...
Paris, France et Camberley, Royaume-Uni – 31 janvier 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce aujourd'hui le lancement de son nouveau...
Lancement d'un nouveau test moléculaire du coronavirus Paris, France et Camberley, Royaume-Uni – 28 janvier 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce aujourd'hui la publication de son chiffre d’affaires...
Paris, France and Camberley, UK – 28 January 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited revenues for the year ended 31 December...
L'accord commercial concerne des diagnostics moléculaires pour le marché croissant de l'aquaculture et de l'aquariophilie Paris, France et Camberley, UK – 17 janvier 2020 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste...
Commercial agreement includes molecular diagnostics for the growing aquaculture and aquamarine market Paris, France and Camberley, UK – 17 January 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international...
Paris, France et Camberley, Royaume-Uni – 2 janvier 2020 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), un spécialiste international du diagnostic clinique, publie aujourd’hui le bilan mensuel du nombre d’actions échangées au titre du contrat...
Paris, France and Camberley, UK – 2 January 2020 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under...
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
